Affordable Access

deepdyve-link
Publisher Website

MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma.

Authors
  • Hattori, Keiichiro1
  • Sakata-Yanagimoto, Mamiko1
  • Okoshi, Yasushi2, 3
  • Goshima, Yuki4
  • Yanagimoto, Shintaro5
  • Nakamoto-Matsubara, Rie1
  • Sato, Taiki6
  • Noguchi, Masayuki6
  • Takano, Shingo7
  • Ishikawa, Eichi7
  • Yamamoto, Tetsuya7
  • Matsumura, Akira7
  • Chiba, Shigeru1
  • 1 Department of Clinical and Experimental Haematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan. , (Japan)
  • 2 Ibaraki Clinical Education and Training Centre, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan. , (Japan)
  • 3 Department of Haematology, Ibaraki Prefectural Central Hospital, Tsukuba, Ibaraki, Japan. , (Japan)
  • 4 School of Medicine, University of Tsukuba, Tsukuba, Japan. , (Japan)
  • 5 Division for Health Service Promotion, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. , (Japan)
  • 6 Department of Pathology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan. , (Japan)
  • 7 Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan. , (Japan)
Type
Published Article
Journal
British Journal of Haematology
Publisher
Wiley (Blackwell Publishing)
Publication Date
May 2017
Volume
177
Issue
3
Pages
492–494
Identifiers
DOI: 10.1111/bjh.14080
PMID: 27161435
Source
Medline
Keywords
License
Unknown
Report this publication

Statistics

Seen <100 times